Investors Presentation for the quarter and Financial year ended March 31, 2026
ADVANCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Advance Agrolife Limited reported strong Q4FY26 results with total revenue of ₹1,259 million (+40% YoY) and FY26 revenue of ₹6,418 million (+28% YoY). EBITDA for FY26 stood at ₹637 million with margins at 9.99%, up 50 bps from prior year. PAT for FY26 was ₹353 million, up 38% YoY. The company has made significant progress on its backward integration strategy, starting production of Pretilachlor Technical and its intermediate PEDA at Unit I, and planning a new Unit 4 at Gidhani by Q2 FY27. Management targets EBITDA margins of 12-14% by FY29, a 4x expansion in 2,4-D herbicide capacity to 10,000 MT, and increasing export share from 2% to 20% by FY29. CARE Ratings upgraded the company's rating from BBB to BBB+ during Q4.
The strong margin expansion trajectory, backward integration into technical manufacturing, and ambitious export targets position the company for sustained growth and margin improvement. Shareholders can expect continued operational leverage benefits as new capacity comes online.